23 October 2026 ASX Announcement Paradigm Biopharmaceuticals Limited ACN 169 346 963 (Administrators Appointed) Application for extension of the convening period for second meeting of creditors We refer to the appointment of Christopher Pattinson and Hayden White as Joint and Several Voluntary...